SUPV3L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.381800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.081200E-01
Normal-vs-Stage2
1.696830E-01
Normal-vs-Stage3
1.898770E-01
Normal-vs-Stage4
5.987200E-01
Stage1-vs-Stage2
5.504200E-01
Stage1-vs-Stage3
6.984200E-02
Stage1-vs-Stage4
9.140200E-01
Stage2-vs-Stage3
1.340190E-01
Stage2-vs-Stage4
7.175200E-01
Stage3-vs-Stage4
2.295600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.298600E-01
Normal-vs-AfricanAmerican
6.101600E-01
Normal-vs-Asian
6.392400E-01
Caucasian-vs-AfricanAmerican
4.805400E-01
Caucasian-vs-Asian
4.911400E-01
AfricanAmerican-vs-Asian
9.423400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.171400E-01
Normal-vs-Female
2.289800E-01
Male-vs-Female
4.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.807200E-01
Normal-vs-Age(41-60Yrs)
6.091000E-01
Normal-vs-Age(61-80Yrs)
1.523010E-01
Normal-vs-Age(81-100Yrs)
6.570200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.639600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.100200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.041800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.268560E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.467000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.397200E-01
Normal-vs-Daily Drinker
3.753000E-01
Normal-vs-Weekly Drinker
6.845800E-01
Normal-vs-Occasional Drinker
6.306000E-01
Normal-vs-Social Drinker
3.937200E-01
Non Drinker-vs-Daily Drinker
1.606610E-01
Non Drinker-vs-Weekly Drinker
1.020210E-01
Non Drinker-vs-Occasional Drinker
1.507410E-01
Non Drinker-vs-Social Drinker
3.234600E-01
Daily Drinker-vs-Weekly Drinker
5.798000E-01
Daily Drinker-vs-Occasional Drinker
9.797800E-01
Daily Drinker-vs-Social Drinker
8.374000E-01
Weekly Drinker-vs-Occasional Drinker
6.121600E-01
Weekly Drinker-vs-Social Drinker
5.336400E-01
Occasional Drinker-vs-Social Drinker
8.124600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.068800E-01
Normal-vs-Grade 2
8.380800E-01
Normal-vs-Grade 3
8.116800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.273000E-01
Grade 1-vs-Grade 3
2.302600E-01
Grade 1-vs-Grade 4
9.068800E-01
Grade 2-vs-Grade 3
6.323800E-01
Grade 2-vs-Grade 4
8.380800E-01
Grade 3-vs-Grade 4
8.116800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.896590E-01
Normal-vs-NonDiabetic
1.714650E-01
Diabetic-vs-NonDiabetic
8.516200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.751600E-01
Normal-vs-NoPancreatitis
1.566570E-01
Pancreatitis-vs-NoPancreatitis
1.166430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.816800E-01
Normal-vs-N1
1.731790E-01
N0-vs-N1
4.439600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.271800E-01
Normal-vs-TP53-NonMutant
3.643200E-01
TP53-Mutant-vs-TP53-NonMutant
3.317800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
